#Preprint

Kevin Bass, MS

kevinnbass

A preprint published Monday shows that among 175 recovered COVID-19 patients from Shanghai, 30% showed a low neutralizing antibody response, with 10 patients showing undetectable antibodies. https://www.medrxiv.org/content/10.1101/2020.03.30.20047365

Catherine Offord

ce_offord

The latest in @TheScientistLLC’s investigation into the enormous influence #Surgisphere has had on policy and research around the world. This installment: Latin America’s #ivermectin crisis.https://bit.ly/37IbGjy One of the (many)

Ashish K. Jha, MD, MPH

ashishkjha

Dexamethasone RecoveryTrial data outNot yet peer-reviewed but thank goodness for preprintA few reflections1. The randomization worked. The groups were pretty balanced2. They pre-specified their subgroups. That's importantSo the results?

Leonid Schneider (visit my site for Covid19 cures)

schneiderleonid

"Our cross sectional study in both COVID-19 out- and inpatients strongly suggests that daily smokers have a very much lower probability of developing symptomatic or severe SARS-CoV-2 infection as compared

Eric Topol

EricTopol

Today's "breakthrough" announcement is unlikely to be any breakthrough.1. Convalescent plasma has no randomized trials. It contains many antibodies that have no neutralizing effect. If it has efficacy, it will

Rebecca Saxe

rebecca_saxe

We posted a preprint today: “The need to connect: Acute social isolation causes neural craving responses similar to hunger.” Lead author @livia_tomova. https://www.biorxiv.org/content/10.1101/2020.03.25.006643v1A thread on what we did,

Jameson Voss MD MPH

JamesonVoss

Why do I wish there was more focus on the convalescent plasma preprint than the @NEJM remdesivir study? Let me give you 10 quick reasons to spread the news about

simine vazire

siminevazire

Is pre-registration a proposal aimed at reducing bias/QRPs? Arguably yes, but I don’t think that’s how we should think of it. 1/n(Note: this was inspired by one sentence taken slightly

Paul Schmidt

paulrschmidt

We find continuous phenotypic and genomic adaptation in response to rapid environmental change in Drosophila - preprint doi: https://doi.org/10.1101/2021.04.27.441526Work co-led by @SethRudman, @sharGblum, and @RajpurohitLab and in collabor

💧Robyn D💦

KoparaFallsKid

OK, all the freedom warriors, don't attack me (I will ignore such for reasons outlined herein) but I installed & activated the #COVIDSafe app. Yes, in my view it is

Philipp Koellinger

PKoellinger

1/4 Interesting: A wet lab study from Germany suggests that some degree of limited background immunity against #COVID19 may exist in the population (~1/3 of their healthy donor sample) due

Yonatan Grad

yhgrad

New preprint: Here we report quantitative prospective longitudinal testing from @nba players, staff and vendors & consider how these data can be used to improve diagnostic and surveillance testing algorithms.

Natalie E. Dean, PhD

nataliexdean

I had the opportunity to write a comment about findings from a large vaccination cohort study in Scotland. I use the comment to discuss some of the challenges of observational

Christian Althaus

C_Althaus

New preprint with @skepteis, @AnthonyHauser5 and @JulRiou where we investigate counterfactual scenarios of an earlier and later implementation of non-pharmaceutical interventions (NPIs) against #SARSCoV2 in Switzerland @ISPMBern @unibern (1

Florian Cova

CovaFlorian

New preprint online: “Quick and dirty”: Intuitive cognitive style predicts trust in Didier Raoult and his hydroxychloroquine-based treatment against COVID-19https://psyarxiv.com/ju62p In three studies, we investigate the relations

Ryan Roemmich

RyanRoemmich

Traditionally, people learn new gait patterns via extensive practice walking in a new environment or in response to instructions from a clinician. In our new preprint, we asked: could people